MediciNova Financial Statements From 2010 to 2025
| MNOV Stock | USD 1.51 0.04 2.72% |
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as , as well as many indicators such as . MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
MediciNova | Build AI portfolio with MediciNova Stock |
MediciNova Company Return On Asset Analysis
MediciNova's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MediciNova Return On Asset | -0.13 |
Most of MediciNova's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MediciNova is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, MediciNova has a Return On Asset of -0.1297. This is 98.52% lower than that of the Biotechnology sector and 99.45% lower than that of the Health Care industry. The return on asset for all United States stocks is 7.36% lower than that of the firm.
MediciNova Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MediciNova's current stock value. Our valuation model uses many indicators to compare MediciNova value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MediciNova competition to find correlations between indicators driving MediciNova's intrinsic value. More Info.MediciNova is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value MediciNova by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About MediciNova Financial Statements
MediciNova investors use historical fundamental indicators, such as MediciNova's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California. Medicinova operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.